Kiran Matcha

Title: Kiran Matcha: Innovator in Pharmaceutical Chemistry

Introduction

Kiran Matcha is a notable inventor based in Turnhout, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate orexin receptors. His work is essential for advancing treatments for various disorders, including insomnia and depression.

Latest Patents

Kiran Matcha holds a patent for synthetic methods of making (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators. The patent describes processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone. This compound is valuable for commercial manufacturing and may be useful in pharmaceutical compositions aimed at treating conditions mediated by orexin activity.

Career Highlights

Kiran Matcha is currently associated with Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic options that can significantly improve patient outcomes.

Collaborations

Kiran has collaborated with notable colleagues, including Dominique Paul M Depré and Florian Damien Medina. These partnerships enhance the research and development efforts within the company.

Conclusion

Kiran Matcha's contributions to pharmaceutical chemistry and his innovative patent work position him as a key figure in the development of new treatments for disorders related to orexin activity. His ongoing efforts at Janssen Pharmaceutica NV continue to pave the way for advancements in this critical area of healthcare.